Tag archives : Featured

  The SARS-CoV-2 infection presents particular challenges and great risks to patients with thalassaemia and sickle cell disease (SCD) and, if their appropriate clinical management as described in International Guidelines is not safeguarded in the context of national policies developed for fighting COVID-19, their health and quality of life will ...

On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled  »Thalassaemia/SCD and COVID-19: Possible risks and a proposal for a patient pathway during the pandemic », which registered more than 700 participants from all over the world! Experts from Italy & Cyprus, inclufing TIF’s ...

TIF has made an effort to put together a list of studies/clinical trials for treatments and vaccines about COVID-19, which is by no means exhaustive as this situation is ever-changing and research in the area is dramatically intensified. It must be noted that there are currently no FDA or EMA-approved ...

TIF’s Expert Patient and long-standing collaborator and friend, Maria Hadjidemetriou, shares her inspiring and thought-provoking journey with thalassaemia and reflects on the lessons it has taught her. Click on the image to read it!

Is the new coronavirus transfusion transmittable? What is the guidance that internationally acclaimed bodies, such as the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC) and others provide with regard to adequacy and safety of blood and its products? This brand new informational guide about ...

  In an effort to assist national blood services in the development of plans to respond to any emerging infectious threats, as far as the sufficiency or safety of the blood supply are concerned, the World Health Organisation (WHO) produced in 2019 a special document, which discusses the elements that ...

The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate, NVX-CoV2373, proved its ability to produce immune responses and high levels of antibodies against COVID-19 in pre-clinical animal trials, the Gaithersburg, ...

Nurses and other health workers are at the frontlines of COVID-19 response, putting their own health at risk to protect the broader community. This World Health Day, the World Health Organisation (WHO) honors the contribution of nurses and midwives, recognizing their vital role in keeping the world healthy. The global nursing ...

  Given the unprecedented global public health crisis brought on by the COVID-19 pandemic, TIF announces that the celebrations of the International Thalassaemia Day 2020 on the 8th of May, including all the Federation’s activities that were initially programmed, are rescheduled for Monday, 8 September 2020. TIF strongly urges its members ...

TIF continues the efforts to address the questions and concerns of its global patients’ and healthcare professionals’ community about the COVID-19 Pandemic and, in doing so, it has issued 2 brand new informational documents. The TIF-proposed Haemoglobinopathy Patient Pathway for Day Care Centres, Units and Clinics treating patients with thalassaemia ...